阳普医疗
(300030)
| 流通市值：17.69亿 | | | 总市值：20.10亿 |
| 流通股本：2.72亿 | | | 总股本：3.09亿 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 95,314,773.95 | 486,260,010.42 | 349,231,193.17 | 230,956,513.82 |
| 营业总成本 | 79,504,810.86 | 452,644,635.72 | 329,782,171.95 | 224,023,221.08 |
| 其他经营收益 | | | | |
| 营业利润 | 26,819,603.42 | 20,852,468.93 | 27,230,353.48 | 18,264,358.62 |
| 利润总额 | 26,819,317.73 | 22,717,559.24 | 27,926,751.64 | 18,831,585.03 |
| 净利润 | 21,966,657.97 | 15,214,212.98 | 23,445,300.5 | 15,435,311.32 |
| 每股收益 | | | | |
| 其他综合收益 | 32,802.24 | -990,517.45 | 13,386.02 | 4,030.67 |
| 综合收益总额 | 21,999,460.21 | 14,223,695.53 | 23,458,686.52 | 15,439,341.99 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 430,165,051.04 | 423,343,116.21 | 449,093,902.34 | 467,611,047.31 |
| 非流动资产: | | | | |
| 非流动资产合计 | 592,939,111.87 | 603,578,620.44 | 630,652,517.43 | 650,982,478.8 |
| 资产总计 | 1,023,104,162.91 | 1,026,921,736.65 | 1,079,746,419.77 | 1,118,593,526.11 |
| 流动负债: | | | | |
| 流动负债合计 | 295,564,848.01 | 317,872,845.65 | 357,721,924.51 | 401,063,811.63 |
| 非流动负债: | | | | |
| 非流动负债合计 | 50,442,764.22 | 53,951,800.53 | 57,730,207.82 | 61,277,986.53 |
| 负债合计 | 346,007,612.23 | 371,824,646.18 | 415,452,132.33 | 462,341,798.16 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 642,047,770.4 | 620,335,333.87 | 630,833,875.02 | 622,005,052.06 |
| 股东权益合计 | 677,096,550.68 | 655,097,090.47 | 664,294,287.44 | 656,251,727.95 |
| 负债和股东权益合计 | 1,023,104,162.91 | 1,026,921,736.65 | 1,079,746,419.77 | 1,118,593,526.11 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 135,377,412.25 | 585,506,044.48 | 432,530,715.66 | 264,206,777.31 |
| 经营活动现金流出小计 | 106,705,100.39 | 475,610,301.01 | 361,184,802.16 | 247,099,021.84 |
| 经营活动产生的现金流量净额 | 28,672,311.86 | 109,895,743.47 | 71,345,913.5 | 17,107,755.47 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 55,603,697.29 | 301,452,402.08 | 167,202,931.67 | 120,225,111.78 |
| 投资活动现金流出小计 | 98,401,226.94 | 296,474,354.1 | 211,789,714.51 | 147,361,620.89 |
| 投资活动产生的现金流量净额 | -42,797,529.65 | 4,978,047.98 | -44,586,782.84 | -27,136,509.11 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 25,859,675 | 231,400,000 | 192,057,861.11 | 144,067,416.67 |
| 筹资活动现金流出小计 | 46,568,102.51 | 434,720,186.92 | 349,639,333.62 | 260,501,200.67 |
| 筹资活动产生的现金流量净额 | -20,708,427.51 | -203,320,186.92 | -157,581,472.51 | -116,433,784 |
| 汇率变动对现金及现金等价物的影响 | -374,189.77 | 317,527.15 | 511,992.13 | 501,566.71 |
| 现金及现金等价物净增加额 | -35,207,835.07 | -88,128,868.32 | -130,310,349.72 | -125,960,970.93 |
| 期末现金及现金等价物余额 | 123,994,377.61 | 159,202,212.68 | 117,020,731.28 | 121,370,110.07 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -88,128,868.32 | - | -125,960,970.93 |